Drug-induced QT prolongation.
Michowitz
M K
MK
Department of Internal Medicine A, Assaf Harofeh Medical Center, Zerifin, Israel.
Michowitz
Y
Y
Zaidenstien
R
R
Golik
A
A
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D004562:Electrocardiography; D005260:Female; D006634:Histamine H1 Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced* / Q000175:diagnosis*; D008297:Male; D011379:Prognosis; D018570:Risk Assessment
D000889:Anti-Arrhythmia Agents; D000900:Anti-Bacterial Agents; D014150:Antipsychotic Agents; D006634:Histamine H1 Antagonists